Staar Surgical Co. (NASDAQ:STAA) fell 3.6% on Wednesday . The company traded as low as $6.59 and last traded at $6.62, with a volume of 52,762 shares changing hands. The stock had previously closed at $6.87.

A number of brokerages have recently weighed in on STAA. Benchmark Co. upgraded Staar Surgical from a “hold” rating to a “buy” rating and set a $6.00 price target for the company in a report on Wednesday, May 18th. Stephens downgraded Staar Surgical from an “overweight” rating to an “equal weight” rating in a research note on Thursday, May 12th. Zacks Investment Research upgraded Staar Surgical from a “strong sell” rating to a “hold” rating in a research note on Wednesday, July 13th. Finally, Canaccord Genuity restated a “hold” rating and set a $7.00 price objective on shares of Staar Surgical in a research note on Thursday, May 12th.

The company’s market capitalization is $266.43 million. The company has a 50-day moving average price of $6.06 and a 200 day moving average price of $6.55.

Staar Surgical (NASDAQ:STAA) last issued its quarterly earnings data on Wednesday, August 3rd. The company reported ($0.05) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.05). The company had revenue of $21 million for the quarter, compared to analyst estimates of $19.88 million. Staar Surgical’s revenue for the quarter was up 12.4% on a year-over-year basis. Analysts anticipate that Staar Surgical Co. will post ($0.30) earnings per share for the current year.

In related news, Director Richard A. Meier sold 25,000 shares of the stock in a transaction that occurred on Friday, May 20th. The stock was sold at an average price of $5.35, for a total transaction of $133,750.00. Following the completion of the sale, the director now owns 27,149 shares in the company, valued at approximately $145,247.15. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Also, major shareholder Broadwood Partners Lp bought 336,210 shares of the firm’s stock in a transaction that occurred on Monday, May 16th. The shares were acquired at an average price of $5.49 per share, with a total value of $1,845,792.90. The disclosure for this purchase can be found here.

An institutional investor recently raised its position in Staar Surgical stock. Mutual of America Capital Management LLC raised its stake in shares of Staar Surgical Co. (NASDAQ:STAA) by 0.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 216,682 shares of the company’s stock after buying an additional 1,299 shares during the period. Mutual of America Capital Management LLC owned approximately 0.54% of Staar Surgical worth $1,547,000 as of its most recent filing with the SEC.

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.